4Moving Biotech Completes Enrollment in Phase 2a INFLAM MOTION Study Evaluating First-in-class Intra-articular GLP-1 Therapy Targeting Synovitis as a Driver of Pain and Disease Progression in Knee ...
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve ...
Time and motion studies can be a useful way to gather real world evidence of a medical intervention's value. When the efficiency of a drug, medical device, or intervention is the outcome of interest, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results